-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KNxB9XT8VNVAz/Z64cVWZy6eUzWzTNdazzDpdkGWli5I1bLgVBJ77Wc79PNiR5bZ +zQr6xibiyIEvj7HutOskQ== 0000950162-06-000214.txt : 20060214 0000950162-06-000214.hdr.sgml : 20060214 20060214172749 ACCESSION NUMBER: 0000950162-06-000214 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060214 DATE AS OF CHANGE: 20060214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CAVAZZA CLAUDIO CENTRAL INDEX KEY: 0001164803 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 CITY: ROME ITALY STATE: L6 ZIP: 00000 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43408 FILM NUMBER: 06617562 BUSINESS ADDRESS: STREET 1: 901 MARINER'S ISLAND BLVD. STREET 2: SUITE 205 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 901 MARINER'S ISLAND BLVD. STREET 2: SUITE 205 CITY: SAN MATEO STATE: CA ZIP: 94404 SC 13G/A 1 sciclone_claudio13ga4123105.htm SCICLONE PHARMACEUTICALS, INC. - CLAUDIO CAVAZZA SCHEDULE 13GA NO. 4 - 12/31/05 SciClone Pharmaceuticals, Inc. - Claudio Cavazza Schedule 13Ga No. 4 - 12/31/05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13G/A4


Under the Securities Exchange Act of 1934
(Amendment No. 4)*

SciClone Pharmaceuticals, Inc.
(Name of Issuer)


Common Stock, No Par Value
(Title of Class of Securities)


80862K104
(CUSIP Number)


December 31, 2005
(Date of Event which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant
to which this Schedule is filed:

    o  Rule 13d-1(b)
    x  Rule 13d-1(c)
    o  Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


-2-


1.
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
 
Paolo Cavazza
2.
Check the Appropriate Box if a Member of a Group
(See Instructions)                                                                                                         (a) o
                                                                                                                                        (b) o
3.
SEC Use Only
 
4.
Citizenship or Place of Organization
 
Italy
 
5.
Sole Voting Power
 
572,815
Number of
Shares
Beneficially
6.
Shared Voting Power
 
7,436,704
Owned by Each
Reporting
Person With:
7.
Sole Dispositive Power
 
572,815
 
8.
Shared Dispositive Power
 
7,436,704
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
 
8,009,519
10.
Check box if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)                                                                                   o
 
11.
Percent of Class Represented by Amount in Row (9)
 
17.5%
12.
Type of Reporting Person (See Instructions)
 
IN



1.
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
 
Claudio Cavazza
2.
Check the Appropriate Box if a Member of a Group
(See Instructions)                                                                                                               (a) o
                                                                                                                                        & #160;      (b) o
3.
SEC Use Only
 
4.
Citizenship or Place of Organization
 
Italy
 
5.
Sole Voting Power
 
394,615
Number of
Shares
Beneficially
6.
Shared Voting Power
 
6,068,011
Owned by Each
Reporting
Person With:
7.
Sole Dispositive Power
 
394,615
 
8.
Shared Dispositive Power
 
6,068,011
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
 
6,462,626
10.
Check box if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions)                                                                                 o
 
11.
Percent of Class Represented by Amount in Row (9)
 
14.1%
12.
Type of Reporting Person (See Instructions)
 
IN



Item 1(a).
Name of Issuer:
SciClone Pharmaceuticals, Inc.


Item 1(b).
Address of Issuer's Principal Executive Offices:

901 Mariner's Island Boulevard, Suite 205, San Mateo, CA 94404

Item 2(a).
Name of Person Filing:
This statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons")

(i)  Paolo Cavazza
(ii) Claudio Cavazza

Item 2(b).
Address of Principal Business Office:

(i)
Paolo Cavazza
Via Tesserete, 10
Lugano, Switzerland

(ii)
Claudio Cavazza
Via Sudafrica, 20
Rome, Italy 00144

Item 2(c).
Citizenship:

(i)  Paolo Cavazza is an Italian citizen.
(ii)  Claudio Cavazza is an Italian Citizen.

Item 2(d).
Title of Class of Securities:

Common Stock, no par value (the "Shares")

Item 2(e).
CUSIP Number:

80862K104

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a:

This Item 3 is not applicable
 
 

 
-5-
 
Item 4. Ownership:
 
Paolo Cavazza

(a)
Amount beneficially owned:
8,009,519
     
(b)
Percent of class:
17.5%
     
(c)
Number of shares as to which such person has:
  

 
(i)
sole power to vote or to direct the vote:
572,815
 
(ii)
shared power to vote or to direct the vote:
7,436,704
 
(iii)
sole power to dispose or to direct the disposition of:
572,815
 
(iv)
shared power to dispose or to direct the disposition of:
7,436,704

Claudio Cavazza

(a)
Amount beneficially owned:
6,462,626
     
(b)
Percent of class:
14.1%
     
(c)
Number of shares as to which such person has:
  

 
(i)
sole power to vote or to direct the vote:
394,615
 
(ii)
shared power to vote or to direct the vote:
6,068,011
 
(iii)
sole power to dispose or to direct the disposition of:
394,615
 
(iv)
shared power to dispose or to direct the disposition of:
6,068,011

Item 5. Ownership of Five Percent or Less of a Class:

Not Applicable

Item 6. Ownership of More than Five Percent on Behalf of Another Person:

Not Applicable

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

Not Applicable

Item 8. Identification and Classification of Members of the Group:

Not Applicable
 
 

 
-6-
 
Item 9. Notice of Dissolution of Group:

Not Applicable

Item 10. Certification:

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.



SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2006
PAOLO CAVAZZA


By:  /s/ Maurizio Terenzi
Name:   Maurizio Terenzi
Title:     proxy holder authorized

Dated: February 14, 2006
CLAUDIO CAVAZZA


By: /s/ Maurizio Terenzi
Name:   Maurizio Terenzi
Title:     proxy holder authorize











This Schedule 13G was signed under Powers-of-Attorney incorporated by reference to Form 4s filed April 1, 2005


 -----END PRIVACY-ENHANCED MESSAGE-----